Predictors of Conversion to Neurodegenerative Disease in REM Sleep Behavior Disorder
Several prodromal symptoms in REM sleep behavior disorder are highly associated with conversion to neurodegenerative diseases.
Several prodromal symptoms in REM sleep behavior disorder are highly associated with conversion to neurodegenerative diseases.
A regression model showed that efficacy of DMTs significantly decreased until age 53, after which disease progression is not affected by DMTs.
Wearable technology may help monitor on/off states in patients with Parkinson disease in an outpatient setting.
The results suggest a noninvasive method for predicting individualized risk for certain stroke subtypes.
Patients in the 2 highest dosing groups saw significant, sustained improvements over the 12-week study.
The new guidelines focus on helping clinicians decide when to initiate, switch, or discontinue disease-modifying therapies for multiple sclerosis.
Researchers found that high doses of the novel antisense oligonucleotide were associated with lower concentrations of mutant huntingtin protein in the cerebrospinal fluid and brain.
Neurology Advisor will provide live coverage of the 2018 American Academy of Neurology Annual Meeting from Los Angeles, CA.
Further research should focus on establishing whether siponimod exerts its effect on the pathogenic processes associated with disease progression or activity, or both.
The FDA has expanded the treatment window for a clot retrieval device in certain patients presenting with acute ischemic stroke.